Latest Shareholder Approval News

Hexima Limited reveals plans to return capital to shareholders and restructure its board following the closure of its main clinical program and prolonged ASX trading suspension.

Jindalee Lithium has successfully raised $1.5 million through an oversubscribed Share Purchase Plan, exceeding its $1 million target to fund the McDermitt Lithium Project and a US SPAC transaction.

Southern Cross Media Group has secured crucial ACMA approval for its proposed merger with Seven West Media, advancing a major consolidation in Australia’s media landscape. The deal now moves closer to final shareholder approval.

Lightning Minerals has raised A$2.5 million to fund an aggressive Phase 2 drilling program at its Mt Turner Gold Project, following promising Phase 1 results that revealed significant gold mineralisation along a 12km strike.

Culpeo Minerals has raised $3 million through a placement to fund maiden drilling at its Vista Montana copper prospect and follow-up work at Lana Corina in Chile, aiming to advance its promising copper exploration projects.

Pathkey.AI has secured A$2.5 million through a placement and launched a nearly A$1 million rights issue to fund expansion of its AI-driven TrialKey platform and pursue strategic acquisitions, alongside key board changes.

Alvo Minerals has raised $2.26 million through a placement to accelerate drilling and exploration at its Palma Copper-Zinc Project in Brazil, including the promising new Touro Prospect.

Australis Oil and Gas has struck two pivotal deals to advance its Tuscaloosa Marine Shale assets, securing a major US development partner and monetizing producing wells to strengthen its balance sheet.

Havilah Resources has secured a binding term sheet with Sandfire Resources for a potential $210 million earn-in at Kalkaroo, while reporting high-grade uranium results and raising $2 million in a share placement.

Atlantic Lithium has secured £3 million through two share placements with Long State Investments, issuing new warrants and security shares to strengthen its financial footing ahead of Ghana's first lithium mine development.

ECP Emerging Growth Limited reported a modest 2.4% return for FY2025, lagging the ASX Small Ordinaries Index, but is pursuing new strategies including a pre-IPO fund investment and a special dividend to address shareholder value concerns.

InhaleRx Limited has introduced SRX-25, an oral fixed-dose combination therapy targeting Treatment-Resistant Depression, aiming to improve patient access and adherence. The company also secured $1 million in capital to advance clinical development and plans a strategic rebrand.